TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · major macro event coming up
ONC

BeiGene, Ltd.

Healthcare · Biotechnology

356.00$ -0.8% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Cash Flow

BeiGene, Ltd. (ONC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 1,128 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ONC
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-8.7 -40 -90 13 -548 -750 -1,283 -1,299 -1,497 -1,157 -141 1,128
1.6 1.5 1.9 4.8 10 19 32 46 66 88 172 142
6.6 10 11 43 87 134 183 241 303 368 442 511
-1.5 2.3 14 57 -17 -11 151 -118 132 -371 -157 191
0.7 5.3 24 59 141 159 229 315 469 596 529 186
-34 -59 -222 -356 -638 554 -3,168 641 1,077 60 -548 -276
-0.1 -0.1
102 -66 361 145 3.8
52 103 381 490 1,691 86 5,203 3,637 -19 416 193 1,059
10.0 4.0 70 152 501 -120 769 2,993 -508 -689 -547 1,971
-9.3 -45 -113 -46 -689 -909 -1,512 -1,614 -1,966 -1,754 -670 942

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?